| Literature DB >> 31666903 |
Guilherme Tucher1, Flávio Antônio de Souza Castro2, Nuno Domingos Garrido3, Ricardo Jorge Fernandes4.
Abstract
Our aim was to analyze physiological, kinematical and performance changes induced by swimming training in regional age-group athletes. Subjects (15.7 ± 2.2 years old) performed a 4 x 50-m front-crawl test at maximal velocity (10 s rest interval) in weeks 2, 4, 9 and 12 of a 15-week macrocycle. Descriptive statistics were used and the percentage of change and smallest worthwhile change (moderate, 0.6-1.2, and large, > 1.2) were measured. Lactate concentration in the third, seventh and twelfth minute of recovery decreased significantly between weeks 2-9 (14.1, 15.7 and 17.6%) and increased between weeks 9-12 (18.2, 18.6 and 19.8%), with the HR presenting only trivial variations during the training period. Stroke length showed a large decrease in the first 50-m trial between weeks 4-9 (6.2%) and a large increase between weeks 9-12 (3.1%). The stroke rate (in all 50-m trials) increased significantly between weeks 4-9 (3- 7%) and the stroke index had a moderate to large increase in the first and third 50-m trial (3.6 and 7.1%, respectively) between weeks 9-12. The overall time decreased by 1.1% between weeks 2-12, being more evident after week 4. We concluded that physiological, kinematical and performance variables were affected by the period of training in regional age-group swimmers.Entities:
Keywords: kinematics; longitudinal assessment; macrocycle adaptations; performance analysis
Year: 2019 PMID: 31666903 PMCID: PMC6815095 DOI: 10.2478/hukin-2019-0014
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Average absolute and relative volume (per each intensity area) throughout the different periods of the training macrocycle
| Training period | Volume (km) | Aerobic capacity 1 (%) | Aerobic capacity 2 (%) | Aerobic power (%) | Anaerobic lactic (%) | Anaerobic alactic (%) |
|---|---|---|---|---|---|---|
| Basic | 19.2 | 75.5 | 11.2 | 11.2 | 1.5 | 0.4 |
| Specific | 19.5 | 71.0 | 10.4 | 12.3 | 3.4 | 0.7 |
| Competitive | 11.9 | 71.2 | 10.4 | 10.2 | 4.4 | 1.1 |
| Transition | 7.4 | 97.3 | 0 | 0 | 1.4 | 1.4 |
Mean ± SD values of blood lactate concentration (La), decrease in lactate concentration (%Larec), heart rate (HR), stroke length (SL), stroke rate (SR), stroke index (SI), velocity at each 50‐m repetition and its overall mean (v) along weeks 2, 4, 9 and 12 of the swimming training macrocycle
| Variables | Week 2 | Week 4 | Week 9 | Week 12 |
|---|---|---|---|---|
| La3 (mm.l‐1) | 13.0 ± 0.8 | 11.0 ± 2.1 | 11.1 ± 2.8 | 13.2 ± 3.1 |
| La7 (mm.l‐1) | 11.8 ± 0.7 | 9.8 ± 2.5 | 10.0 ± 2.2 | 11.6 ± 2.8 |
| La12 (mm.l‐1) | 10.6 ± 1.9 | 9.6 ± 2.6 | 8.7 ± 2.3 | 10.4 ± 3.2 |
| %Larec3‐7 (%.min‐1) | 2.1 ± 1.0 | 2.7 ± 4.0 | 2.2 ± 3.2 | 2.5 ± 2.2 |
| %Larec3‐12 (%.min‐1) | 2.0 ± 1.4 | 1.4 ± 1.3 | 2.3 ± 1.6 | 2.4 ± 0.8 |
| %Larec7‐12 (%.min‐1) | 2.1 ± 2.9 | 0.06 ± 3.7 | 2.5 ± 2.3 | 2.3 ± 2.4 |
| HR0 (bpm) | 174.8 ± 11.3 | 162.5 ± 27.5 | 166.8 ± 17.8 | 161.3 ± 16.8 |
| HR3 (bpm) | 125.6 ± 9.6 | 113.1 ± 10.7 | 113.0 ± 11.8 | 109.1 ± 20.0 |
| HR7 (bpm) | 111.6 ± 10.4 | 108.8 ± 8.5 | 110.3 ± 8.5 | 104.0 ± 11.2 |
| HR12 (bpm) | 114.0 ± 10.9 | 105.5 ± 8.2 | 108.8 ± 7.4 | 105.1 ± 9.9 |
| SL1 (m.cycle‐1) | 1.97 ± 0.18 | 2.04 ± 0.26 | 1.91 ± 0.12 | 1.97 ± 0.11 |
| SL2 (m.cycle‐1) | 1.95 ± 0.19 | 1.96 ± 0.20 | 1.91 ± 0.18 | 1.91 ± 0.23 |
| SL3 (m.cycle‐1) | 1.92 ± 0.23 | 1.93 ± 0.28 | 1.85 ± 0.23 | 1.94 ± 0.20 |
| SL4 (m.cycle‐1) | 1.90 ± 0.21 | 1.92 ± 0.19 | 1.87 ± 0.14 | 1.83 ± 0.20 |
| SR1 (cycle.min‐1) | 48.01 ± 4.42 | 44.77 ± 6.99 | 47.99 ± 3.50 | 46.66 ± 2.58 |
| SR2 (cycle.min‐1) | 41.50 ± 3.59 | 41.40 ± 4.23 | 42.81 ± 4.04 | 42.89 ± 5.38 |
| SR3 (cycle.min‐1) | 39.16 ± 3.61 | 39.08 ± 4.21 | 40.98 ± 2.49 | 40.03 ± 3.04 |
| SR4 (cycle.min‐1) | 38.74 ± 3.75 | 38.94 ± 3.06 | 40.61 ± 2.08 | 41.04 ± 2.17 |
| SI1 | 3.12 ± 0.41 | 3.07 ± 0.42 | 2.94 ± 0.32 | 3.04 ± 0.33 |
| SI2 | 2.64 ± 0.32 | 2.65 ± 0.34 | 2.59 ± 0.29 | 2.60 ± 0.39 |
| SI3 | 2.40 ± 0.39 | 2.41 ± 0.48 | 2.35 ± 0.46 | 2.52 ± 0.37 |
| SI4 | 2.33 ± 0.34 | 2.40 ± 0.30 | 2.38 ± 0.32 | 2.32 ± 0.47 |
| v1 (m.s‐1) | 1.57 ± 0.11 | 1.50 ± 0.11 | 1.53 ± 0.09 | 1.53 ± 0.10 |
| v2 (m.s‐1) | 1.34 ± 0.05 | 1.34 ± 0.06 | 1.35 ± 0.07 | 1.35 ± 0.08 |
| v3 (m.s‐1) | 1.24 ± 0.07 | 1.24 ± 0.09 | 1.25 ± 0.11 | 1.29 ± 0.07 |
| v4 (m.s‐1) | 1.22 ± 0.06 | 1.24 ± 0.04 | 1.26 ± 0.08 | 1.25 ± 0.12 |
| voverall (m.s‐1) | 1.33 ± 0.06 | 1.32 ± 0.05 | 1.34 ± 0.07 | 1.35 ± 0.08 |
Effect size (mean ± 95% confidence limit) for blood lactate concentration (La), percentage of average decrease in the lactate concentration (%Larec), stroke length (SL), stroke rate (SR), stroke index (SI), 50‐m velocity from the first, second and fourth 50‐m repetitions (v1, v3 and v4) and overall velocities (voverall) found between the testing weeks 2, 4, 9 and 12 (W)
| Variables | W2‐W4 | W2‐W9 | W2‐W12 | W4‐W9 | W4‐W12 | W9‐W12 |
|---|---|---|---|---|---|---|
| La3 | 2.6 ± 2.2% | 2.0 ± 2.3% | ‐ | ‐ | ‐ | 3.0 ± 2.3% |
| La7 | 2.5 ± 2.2% | 2.5 ± 2.2% | ‐ | ‐ | 2.2 ± 2.3% | 3.4 ± 2.3% |
| La12 | 1.6 ± 2.4% | 2.2 ± 2.3% | ‐ | 1.6 ± 2.3% | ‐ | 1.8 ± 2.3% |
| %Larec3‐12 | ‐ | ‐ | ‐ | ‐ | 2.9 ± 2.3% | ‐ |
| %Larec7‐12 | 2.0 ± 2.3% | ‐ | ‐ | ‐ | 1.6 ± 2.3% | ‐ |
| SL1 | ‐ | 1.1 ± 1.8% | ‐ | 1.5 ± 2.3% | ‐ | 1.3 ± 2.2% |
| SL2 | ‐ | ‐ | ‐ | 1.6 ± 2.3% | ‐ | ‐ |
| SL3 | ‐ | 1.4 ± 2.3% | ‐ | 1.5 ± 2.3% | ‐ | ‐ |
| SL4 | ‐ | ‐ | 1.2 ± 2.0% | 1.4 ± 2.2% | 1.3 ± 2.2% | ‐ |
| SR1 | 1.3 ± 2.2% | ‐ | 1.1 ± 1.8% | 1.5 ± 2.3% | ‐ | ‐ |
| SR2 | ‐ | 1.7 ± 2.1% | ‐ | 1.6 ± 2.3% | ‐ | ‐ |
| SR3 | ‐ | 3.2 ± 2.1% | ‐ | 1.9 ± 2.2% | ‐ | ‐ |
| SR4 | ‐ | 1.5 ± 1.9% | 2.1 ± 2.3% | 1.6 ± 2.0% | 1.9 ± 2.3% | ‐ |
| SI1 | ‐ | 2.4 ± 2.3% | ‐ | 1.3 ± 2.2% | ‐ | 1.4 ± 2.3% |
| SI3 | ‐ | ‐ | 1.3 ± 2.2% | ‐ | ‐ | 1.1 ± 1.8% |
| v1 | 2.4 ± 2.3% | 2.8 ± 2.2% | 1.9 ± 2.3% | 1.7 ± 2.3% | 1.6 ± 2.3% | ‐ |
| v3 | ‐ | ‐ | 2.6 ± 2.2% | ‐ | 1.7 ± 2.3% | 1.1 ± 2.3% |
| v4 | 1.6 ± 2.3% | 2.0 ± 2.3% | 1.1 ± 2.3% | 1.2 ± 2.3% | ‐ | ‐ |
| voverall | ‐ | ‐ | 1.2 ± 2.3% | 1.5 ± 2.3% | 1.5 ± 2.3% | ‐ |
Note: effect size refers only to variables with beneficial effect
Effect: moderate, 0.6‐1.2; and large, > 1.2